Ocwen and NeighborWorks® Sacramento Launch Targeted California Campaign To Help Struggling Borrowers
Dec 07, 2016 12:15 pm UTC| Business
WEST PALM BEACH, Fla., Dec. 07, 2016 -- Ocwen Financial Corporation (NYSE:OCN), a leading financial services holding company, and NeighborWorks® HomeOwnership Center Sacramento Region (NeighborWorks® Sacramento), a...
Dec 07, 2016 12:00 pm UTC| Business
Updated Data from Phase 1b Triplet Combination Trial at SABCS; Increased Median PFS to 7.8 Months and ORR to 61 Percent; Median Duration of Response (MDR) at 10 Months in Third-line Setting for Patients With and Without...
Broadwind Energy Announces $23 Million in New Tower Orders
Dec 07, 2016 12:00 pm UTC| Business
CICERO, Ill., Dec. 07, 2016 -- Broadwind Energy, Inc. (NASDAQ:BWEN) today announced $23 million in new tower orders. Broadwind will produce these towers in its Manitowoc, WI and Abilene, TX facilities for 2017...
Dec 07, 2016 12:00 pm UTC| Business
DANVERS, Mass., Dec. 07, 2016 -- Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support and recovery technologies, today announced it has expanded its U.S. Food and Drug Administration (FDA)...
Platform Specialty Products Corporation Completes Repricing of $1.3 Billion of Term Loans
Dec 07, 2016 12:00 pm UTC| Business
WEST PALM BEACH, Fla., Dec. 07, 2016 -- Platform Specialty Products Corporation (NYSE:PAH) ("Platform"), a global specialty chemicals company, today announced that it successfully completed the repricing of $1.3 billion...
Arcadis North America Appoints New City Leader in Chicago
Dec 07, 2016 12:00 pm UTC| Business
CHICAGO, Dec. 07, 2016 -- Arcadis North America today announced the appointment of Alan Baxter as the company’s new city executive for Chicago. In his role at Arcadis, Baxter will be responsible for expanding the...
Lysogene Appoints David Schilansky to Board of Directors
Dec 07, 2016 12:00 pm UTC| Business
PARIS, Dec. 07, 2016 -- Lysogene, a biopharmaceutical company specializing in gene therapy for rare central nervous system diseases, appointed David Schilansky to the board of directors, as a non-executive, independent...